Telcon RF Pharmaceutical (XKRX:200230) Total Liabilities : ₩35,208 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Telcon RF Pharmaceutical Total Liabilities?

Telcon RF Pharmaceutical's Total Liabilities for the quarter that ended in Mar. 2024 was ₩35,208 Mil.

Telcon RF Pharmaceutical's quarterly Total Liabilities increased from Sep. 2023 (₩30,509.20 Mil) to Dec. 2023 (₩35,470.38 Mil) but then declined from Dec. 2023 (₩35,470.38 Mil) to Mar. 2024 (₩35,207.59 Mil).

Telcon RF Pharmaceutical's annual Total Liabilities declined from Dec. 2021 (₩61,422.02 Mil) to Dec. 2022 (₩35,119.60 Mil) but then increased from Dec. 2022 (₩35,119.60 Mil) to Dec. 2023 (₩35,470.38 Mil).

Telcon RF Pharmaceutical Total Liabilities Historical Data

The historical data trend for Telcon RF Pharmaceutical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telcon RF Pharmaceutical Total Liabilities Chart

Telcon RF Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

16,361.86

93,577.13

61,422.02

35,119.60

35,470.38

Telcon RF Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															32,372.44	30,427.21	30,509.20	35,470.38	35,207.59

Telcon RF Pharmaceutical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Telcon RF Pharmaceutical's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	34923.951	+	(403.02	+	143.412
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	35,470

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	140414.917	-	104944.534
	=	35,470

Telcon RF Pharmaceutical's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	34760.659	+	(303.422	+	143.513
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	35,208

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	132786.622	-	97579.028
	=	35,208

Telcon RF Pharmaceutical Total Liabilities Related Terms

Thank you for viewing the detailed overview of Telcon RF Pharmaceutical's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Telcon RF Pharmaceutical (XKRX:200230) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Telcon RF Pharmaceutical Inc (XKRX:200230) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

684, Dongtangiheung-ro, Giheung-gu, Gyeonggi-do, Yongin-si, KOR, 17102

Website

http://www.telcon.co.kr

Telcon RF Pharmaceutical Inc manufactures wireless communication equipment. It is engaged in developing connectors for input and output port, board to board, cable assembly, and board to mount used in wireless communication equipment. The company also supply's RF coaxial connectors.

Telcon RF Pharmaceutical (XKRX:200230) Headlines

No Headlines